Epstein Secrets

investment objectives for this account if you have questions about these objectives, disagree with them, or with to change them, please contact you Franco' Advisor or Branch Manager. You can find a ful description of the alternative investment objectives in important information about your sratementat

the nos calt foe eaty rsderpbon ad beskald crust-tidy by lot torn amcsj 8A sonniesof that ape Winos name a n sensate nave for es clones Cat leas 'Mesta co is Standtom thrd pale; and is wry 6 rot %Waited Otis call leases miryeast vasch could Sett Ski Cantle% olorma kin esd beprodded open regent •

01 Community Organizations, LLC Andrew Gallivan 3/9/2017 no material changes no material changes Yes No Rosemary Vrablic 82546 00000418627 Franco, Isaac S. Andrew Gallivan 3/1/2017 no changes from KYC No changes from KYC Yes No Rosemary Vrablic 82549 00000435806 EFTA01398815 Franco

lients [I] From: Andrew Gallivan Date: Fri, 07 Apr 2017 To: Vaishali-P Mehta < Classification: For internal use only Approved. From: Vaishali-P Mehta Sent: Friday, April 07, 2017 2:21 PM To: Andrew Gallivan Subject: FW: MD approval for ACUs completed for High Risk Clients [I] Classification: Fo

01 Community Organizations, LLC Andrew Gallivan 3/9/2017 no material changes no material changes Yes No Rosemary Vrablic 82546 00000418627 Franco, Isaac S. Andrew Gallivan 3/1/2017 no changes from KYC No changes from KYC Yes No Rosemary Vrablic 82549 00000435806 EFTA01398877 Franco

USA {https://brandportal.intranet.db.com/img/modules/claim_en_rgb.gif} Securities offered through Deutsche Bank Securities Inc. From: Vaishali-P Mehta Sent: Wednesday, April 05, 2017 12:23 PM To: Andrew Gallivan Cc: Mark Gonzalez; Rachel Maglicic; Stewart Oldfield; Brian P Convey; Joanne Jensen;